HEPATIC DYSPLASIA

This adverse event was reported 14 times

HEPATIC DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NITISINONE 1 0.0010
1 FAM-TRASTUZUMAB DERUXTECAN-NXKI 1 0.0001
2 RITONAVIR 100 MG 1 0.0001
3 EZETIMIBE AND SIMVASTATIN 1 0.0001
4 ALEMTUZUMAB 1 0.0001
5 SOFOSBUVIR 1 0.0001
6 FILGRASTIM 1 0.0000
7 TERIFLUNOMIDE 1 0.0000
8 VENETOCLAX 1 0.0000
9 RIBAVIRIN 1 0.0000
See all drugs enriched for association with HEPATIC DYSPLASIA